JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5051
Alerus Financial
ALRS
$812M
| $154K | ﹤0.01% |
7,878
-28,990
| -79% | -$572K |
2019 Q4
18 quarters
|
|
5052
Alta Equipment Group
ALTG
$209M
| $154K | ﹤0.01% |
19,200
-90,650
| -83% | -$917K |
2020 Q2
16 quarters
|
|
5053
Invesco S&P MidCap Momentum ETF
XMMO
$7.24B
| $154K | ﹤0.01% |
1,354
-2,654
| -66% | -$300K |
2023 Q4
2 quarters
|
|
|
QVCGA
5054
DELISTED
QVC Group Inc Series A
QVCGA
| $154K | ﹤0.01% |
4,887
-30,231
| -86% | -$1.26M |
2013 Q2
44 quarters
|
|
5055
Universal Electronics
UEIC
$71M
| $154K | ﹤0.01% |
13,232
+2,534
| +24% | +$28.4K |
2013 Q2
44 quarters
|
|
|
NYAX
5056
Nayax
NYAX
$1.84B
| $153K | ﹤0.01% |
7,175
-37,311
| -84% | -$942K |
2023 Q2
4 quarters
|
|
5057
Atea Pharmaceuticals
AVIR
$411M
| $153K | ﹤0.01% |
46,216
-57,040
| -55% | -$213K |
2020 Q4
14 quarters
|
|
5058
Northern Trust Morningstar Developed Markets ex-US Factor Tilt ETF
TLTD
$663M
| $152K | ﹤0.01% |
+2,179
| New | +$155K |
2024 Q2
0 quarters
|
|
5059
Tejon Ranch
TRC
$445M
| $152K | ﹤0.01% |
8,920
-39,511
| -82% | -$656K |
2015 Q4
34 quarters
|
|
5060
Lexicon Pharmaceuticals
LXRX
$814M
| $152K | ﹤0.01% |
90,426
+290
| +0.3% | +$520 |
2015 Q3
35 quarters
|
|
5061
Hingham Institution for Saving
HIFS
$632M
| $152K | ﹤0.01% |
849
-601
| -41% | -$104K |
2016 Q3
31 quarters
|
|
5062
iShares MSCI Emerging Markets Asia ETF
EEMA
$900M
| $152K | ﹤0.01% |
2,093
-612
| -23% | -$43.1K |
2019 Q2
20 quarters
|
|
5063
American Coastal Insurance
ACIC
$439M
| $152K | ﹤0.01% |
14,379
+2,375
| +20% | +$26.7K |
2017 Q2
28 quarters
|
|
5064
James Hardie Industries
JHX
$14.6B
| $151K | ﹤0.01% |
4,801
+93
| +2% | +$3.2K |
2015 Q1
37 quarters
|
|
5065
Schwab International Small-Cap Equity ETF
SCHC
$5.6B
| $151K | ﹤0.01% |
4,244
-11,688
| -73% | -$417K |
2021 Q3
11 quarters
|
|
5066
Entrada Therapeutics
TRDA
$212M
| $151K | ﹤0.01% |
10,570
+2,157
| +26% | +$30.7K |
2022 Q4
6 quarters
|
|
|
RPC
5067
Ridgepost Capital
RPC
$841M
| $150K | ﹤0.01% |
17,739
-61,916
| -78% | -$494K |
2023 Q2
4 quarters
|
|
5068
Citizens & Northern Corp
CZNC
$457M
| $150K | ﹤0.01% |
8,395
-19,083
| -69% | -$334K |
2013 Q2
44 quarters
|
|
|
JUNM
5069
FT Vest U.S. Equity Max Buffer ETF - June
JUNM
$67.4M
| $150K | ﹤0.01% |
+4,912
| New | +$150K |
2024 Q2
0 quarters
|
|
|
VRNA
5070
DELISTED
Verona Pharma
VRNA
| $150K | ﹤0.01% |
10,364
-7,277
| -41% | -$106K |
2022 Q3
7 quarters
|
|
5071
Shore Bancshares
SHBI
$767M
| $150K | ﹤0.01% |
13,084
-37,075
| -74% | -$402K |
2021 Q4
10 quarters
|
|
5072
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.43B
| $149K | ﹤0.01% |
3,650
-16,211
| -82% | -$695K |
2022 Q2
8 quarters
|
|
5073
Build-A-Bear
BBW
$315M
| $149K | ﹤0.01% |
5,897
+154
| +3% | +$4.34K |
2022 Q2
8 quarters
|
|
5074
Rigel Pharmaceuticals
RIGL
$873M
| $149K | ﹤0.01% |
18,098
+7,827
| +76% | +$81.9K |
2016 Q2
32 quarters
|
|
5075
Baytex Energy
BTE
$3.24B
| $149K | ﹤0.01% |
42,700
-25,792
| -38% | -$92.3K |
2023 Q1
5 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.